Open AccessPatient-Reported Outcome Results from the Open-Label Randomized Phase III SELECT BC Trial Evaluating First-Line S-1 Therapy for Metastatic Breast Cancer
Author(s) -
Takuya Kawahara,
Kojiro Shimozuma,
Takeru Shiroiwa,
Yasuhiro Hagiwara,
Yukari Uemura,
Takanori Watanabe,
Naruto Taira,
Takashi Fukuda,
Yasuo Ohashi,
Hirofumi Mukai
Publication year - 2017
Publication title -
oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.987
H-Index - 98
eISSN - 1423-0232
pISSN - 0030-2414
DOI - 10.1159/000484142
Subject(s) - medicine , breast cancer , taxane , quality of life (healthcare) , metastatic breast cancer , oncology , randomized controlled trial , cancer , physical therapy , nursing
To evaluate the effects of S-1, an orally administered 5-FU agent, versus taxane on patient-reported outcomes (PROs) in the SELECT BC trial.